Pages that link to "Q44080052"
Jump to navigation
Jump to search
The following pages link to Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? (Q44080052):
Displaying 50 items.
- Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis (Q24243149) (← links)
- Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis (Q24247315) (← links)
- Nonalcoholic fatty liver disease (Q24555779) (← links)
- Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link (Q24631619) (← links)
- Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame (Q26775571) (← links)
- Genetic background in nonalcoholic fatty liver disease: A comprehensive review (Q26780248) (← links)
- Endocrine causes of nonalcoholic fatty liver disease (Q26780254) (← links)
- Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols (Q26783881) (← links)
- Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? (Q26824893) (← links)
- Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals (Q26859118) (← links)
- Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease (Q27481042) (← links)
- Nonalcoholic Fatty Liver Disease: Pathophysiology and Management (Q30241387) (← links)
- Obesity, adipokines and hepatocellular carcinoma (Q30427127) (← links)
- The effects of diet composition on body fat and hepatic steatosis in an animal (Peromyscus californicus) model of the metabolic syndrome. (Q30431218) (← links)
- Pathogenesis of non-alcoholic fatty liver disease. (Q33606303) (← links)
- Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease (Q33612394) (← links)
- The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease (Q33653828) (← links)
- Repeated sense of hunger leads to the development of visceral obesity and metabolic syndrome in a mouse model (Q33690123) (← links)
- Nonalcoholic fatty liver disease: Diagnostic biomarkers. (Q33706254) (← links)
- Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease (Q33719929) (← links)
- Inflammatory mediators of hepatic steatosis. (Q33734136) (← links)
- Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas (Q33867088) (← links)
- Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations (Q33948324) (← links)
- Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance (Q34200821) (← links)
- Gender-related variations in iron metabolism and liver diseases (Q34391646) (← links)
- Leptin in hepatocellular carcinoma (Q34406436) (← links)
- Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development (Q34589677) (← links)
- Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis (Q34635693) (← links)
- Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. (Q34779049) (← links)
- Predictors of non-alcoholic fatty liver disease in obese and overweight Egyptian children: Single center study (Q34996081) (← links)
- Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity (Q35113836) (← links)
- Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease (Q35200808) (← links)
- Diagnosis and evaluation of nonalcoholic fatty liver disease (Q35495753) (← links)
- Serum autotaxin is independently associated with hepatic steatosis in women with severe obesity. (Q35553828) (← links)
- Serum adipokine and ghrelin levels in nonalcoholic steatohepatitis (Q35598565) (← links)
- Fat, diabetes, and liver injury in chronic hepatitis C. (Q35628100) (← links)
- Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease. (Q35769146) (← links)
- Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis (Q35788887) (← links)
- The ins and outs of mitochondrial dysfunction in NASH. (Q35821156) (← links)
- Gender Specific Association of Serum Leptin and Insulinemic Indices with Nonalcoholic Fatty Liver Disease in Prediabetic Subjects (Q35841726) (← links)
- Nonalcoholic fatty liver disease: a review of current understanding and future impact (Q35996525) (← links)
- Nonalcoholic fatty liver disease: a clinical review (Q36042906) (← links)
- Biliary lipids and cholesterol crystal formation in leptin-deficient obese mice (Q36063398) (← links)
- Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity (Q36076151) (← links)
- Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease (Q36083468) (← links)
- Should nonalcoholic fatty liver disease be renamed? (Q36141458) (← links)
- Insulin resistance and steatosis in hepatitis C virus infection. (Q36160709) (← links)
- A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease (Q36172470) (← links)
- Benefits of lifestyle modification in NAFLD. (Q36172840) (← links)
- Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice (Q36243894) (← links)